OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk

OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk

Disclosure: M. Ollila: None. R.K. Arffman: None. L. Morin-Papunen: None. E. Korhonen: None. M. Gissler: None. T.T. Piltonen: None. Women with polycystic ovary syndrome (PCOS) are burdened with multimorbidity, but there is only limited knowledge on mortality. Here, we investigated in a register-based...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the Endocrine Society 2023-10, Vol.7 (Supplement_1)
Hauptverfasser: Ollila, Meri-Maija, Arffman, Riikka K, Morin-Papunen, Laure, Korhonen, Elisa, Gissler, Mika, Piltonen, Terhi T
Format: Artikel
Sprache:eng
Schlagworte:
Reproductive Endocrinology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_1
container_start_page
container_title Journal of the Endocrine Society
container_volume 7
creator Ollila, Meri-Maija
Arffman, Riikka K
Morin-Papunen, Laure
Korhonen, Elisa
Gissler, Mika
Piltonen, Terhi T
description Disclosure: M. Ollila: None. R.K. Arffman: None. L. Morin-Papunen: None. E. Korhonen: None. M. Gissler: None. T.T. Piltonen: None. Women with polycystic ovary syndrome (PCOS) are burdened with multimorbidity, but there is only limited knowledge on mortality. Here, we investigated in a register-based 1:3 matched case-control study, whether women with PCOS have increased all-cause, or cause-specific mortality compared to women without PCOS. Women with PCOS (i.e., cases) were identified from the Finnish Care Register for Health Care using the International Classification of Diseases, Revisions 8, 9, and 10 (ICD-8, ICD-9, and ICD-10, respectively) codes for PCOS (ICD-10: E28.2, ICD-9: 256.4, ICD-8: 256.9). Control women were matched according to the year of birth and residential area. The time and cause of death as well as the highest level of education were extracted from the register of Statistics Finland. The registers covered the years 1969-2019. Crude and education-adjusted Cox proportional hazard models were applied, and the results were reported as hazard ratio (HR) with 95% confidence intervals. The study included 9,839 women with PCOS and 70,705 controls. Overall, 1,003 controls and 177 women with PCOS died during the follow-up period. The women with PCOS died significantly younger than the controls (51.4 ± 16.4 versus 52.9 ± 16.6 years, p
doi_str_mv 10.1210/jendso/bvad114.1712
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10554621</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_10554621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1952-4b3ad2b27a34cb819afbb81fb984d7c4dc66c6d76e61c172d336672f497b046e3</originalsourceid><addsrcrecordid>eNpVkNtKAzEQhoMoWLRP4E1eYNtMkk26V1KKh0KlpSpehpzWpm43ZbMW9u3d0iJ69Q_zMx_Dh9AdkBFQIOOtr12KY3PQDoCPQAK9QAPKJc2gkPTyz3yNhiltCSFQMF5wPkCr5ZrlGRF4FavOdqkNFi8Puunwa1e7Ju48nic8TSnaoFvv8EdoN1jXeF7bxuvUb15i0-oqtB1eh_R1i65KXSU_POcNen98eJs9Z4vl03w2XWQWipxm3DDtqKFSM27NBApdmj5KU0y4k5Y7K4QVTgovwIKkjjEhJC15IQ3hwrMbdH_i7r_Nzjvr67bRldo3Ydd_r6IO6n9Th436jAcFJM-5oNAT2Ilgm5hS48vfYyDqaFadzKqzWXU0y34A0mpv7A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><creator>Ollila, Meri-Maija ; Arffman, Riikka K ; Morin-Papunen, Laure ; Korhonen, Elisa ; Gissler, Mika ; Piltonen, Terhi T</creator><creatorcontrib>Ollila, Meri-Maija ; Arffman, Riikka K ; Morin-Papunen, Laure ; Korhonen, Elisa ; Gissler, Mika ; Piltonen, Terhi T</creatorcontrib><description>Disclosure: M. Ollila: None. R.K. Arffman: None. L. Morin-Papunen: None. E. Korhonen: None. M. Gissler: None. T.T. Piltonen: None. Women with polycystic ovary syndrome (PCOS) are burdened with multimorbidity, but there is only limited knowledge on mortality. Here, we investigated in a register-based 1:3 matched case-control study, whether women with PCOS have increased all-cause, or cause-specific mortality compared to women without PCOS. Women with PCOS (i.e., cases) were identified from the Finnish Care Register for Health Care using the International Classification of Diseases, Revisions 8, 9, and 10 (ICD-8, ICD-9, and ICD-10, respectively) codes for PCOS (ICD-10: E28.2, ICD-9: 256.4, ICD-8: 256.9). Control women were matched according to the year of birth and residential area. The time and cause of death as well as the highest level of education were extracted from the register of Statistics Finland. The registers covered the years 1969-2019. Crude and education-adjusted Cox proportional hazard models were applied, and the results were reported as hazard ratio (HR) with 95% confidence intervals. The study included 9,839 women with PCOS and 70,705 controls. Overall, 1,003 controls and 177 women with PCOS died during the follow-up period. The women with PCOS died significantly younger than the controls (51.4 ± 16.4 versus 52.9 ± 16.6 years, p&lt;0.001). In the unadjusted analysis, women with PCOS had increased overall mortality (HR=1.53 [1.28-1.84]) as well as increased mortality due to tumors (HR=1.42 [1.06-1.90]), endocrine, nutrition, or metabolic diseases (HR=2.45 [1.02-5.96]), and diseases of the circulatory system (HR=1.77 [1.19-2.62]). In the adjusted analysis, women with PCOS had increased overall mortality (HR=1.47 [1.23-1.76]), as well as increased mortality due to diseases of the circulatory system (HR=1.67 [1.13-2.48]) and tumors (HR=1.38 [1.04-1.85]). Regarding more specific causes of death, women with PCOS had increased mortality due to diabetes (HR=3.07 [1.16-8.08]), other diseases of the circulatory system (HR=2.07 [1.00-4.25]), and bronchitis (HR=3.61 [1.01-12.88]) in the adjusted analyses. In conclusion, PCOS is a severe lifelong syndrome that increases mortality. More emphasis should be targeted on the prevention and treatment of diabetes, circulatory diseases, tumors, and respiratory diseases in women with PCOS to reduce the mortality risk. Presentation Date: Sunday, June 18, 2023</description><identifier>ISSN: 2472-1972</identifier><identifier>EISSN: 2472-1972</identifier><identifier>DOI: 10.1210/jendso/bvad114.1712</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Reproductive Endocrinology</subject><ispartof>Journal of the Endocrine Society, 2023-10, Vol.7 (Supplement_1)</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1952-4b3ad2b27a34cb819afbb81fb984d7c4dc66c6d76e61c172d336672f497b046e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554621/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554621/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Ollila, Meri-Maija</creatorcontrib><creatorcontrib>Arffman, Riikka K</creatorcontrib><creatorcontrib>Morin-Papunen, Laure</creatorcontrib><creatorcontrib>Korhonen, Elisa</creatorcontrib><creatorcontrib>Gissler, Mika</creatorcontrib><creatorcontrib>Piltonen, Terhi T</creatorcontrib><title>OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk</title><title>Journal of the Endocrine Society</title><description>Disclosure: M. Ollila: None. R.K. Arffman: None. L. Morin-Papunen: None. E. Korhonen: None. M. Gissler: None. T.T. Piltonen: None. Women with polycystic ovary syndrome (PCOS) are burdened with multimorbidity, but there is only limited knowledge on mortality. Here, we investigated in a register-based 1:3 matched case-control study, whether women with PCOS have increased all-cause, or cause-specific mortality compared to women without PCOS. Women with PCOS (i.e., cases) were identified from the Finnish Care Register for Health Care using the International Classification of Diseases, Revisions 8, 9, and 10 (ICD-8, ICD-9, and ICD-10, respectively) codes for PCOS (ICD-10: E28.2, ICD-9: 256.4, ICD-8: 256.9). Control women were matched according to the year of birth and residential area. The time and cause of death as well as the highest level of education were extracted from the register of Statistics Finland. The registers covered the years 1969-2019. Crude and education-adjusted Cox proportional hazard models were applied, and the results were reported as hazard ratio (HR) with 95% confidence intervals. The study included 9,839 women with PCOS and 70,705 controls. Overall, 1,003 controls and 177 women with PCOS died during the follow-up period. The women with PCOS died significantly younger than the controls (51.4 ± 16.4 versus 52.9 ± 16.6 years, p&lt;0.001). In the unadjusted analysis, women with PCOS had increased overall mortality (HR=1.53 [1.28-1.84]) as well as increased mortality due to tumors (HR=1.42 [1.06-1.90]), endocrine, nutrition, or metabolic diseases (HR=2.45 [1.02-5.96]), and diseases of the circulatory system (HR=1.77 [1.19-2.62]). In the adjusted analysis, women with PCOS had increased overall mortality (HR=1.47 [1.23-1.76]), as well as increased mortality due to diseases of the circulatory system (HR=1.67 [1.13-2.48]) and tumors (HR=1.38 [1.04-1.85]). Regarding more specific causes of death, women with PCOS had increased mortality due to diabetes (HR=3.07 [1.16-8.08]), other diseases of the circulatory system (HR=2.07 [1.00-4.25]), and bronchitis (HR=3.61 [1.01-12.88]) in the adjusted analyses. In conclusion, PCOS is a severe lifelong syndrome that increases mortality. More emphasis should be targeted on the prevention and treatment of diabetes, circulatory diseases, tumors, and respiratory diseases in women with PCOS to reduce the mortality risk. Presentation Date: Sunday, June 18, 2023</description><subject>Reproductive Endocrinology</subject><issn>2472-1972</issn><issn>2472-1972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkNtKAzEQhoMoWLRP4E1eYNtMkk26V1KKh0KlpSpehpzWpm43ZbMW9u3d0iJ69Q_zMx_Dh9AdkBFQIOOtr12KY3PQDoCPQAK9QAPKJc2gkPTyz3yNhiltCSFQMF5wPkCr5ZrlGRF4FavOdqkNFi8Puunwa1e7Ju48nic8TSnaoFvv8EdoN1jXeF7bxuvUb15i0-oqtB1eh_R1i65KXSU_POcNen98eJs9Z4vl03w2XWQWipxm3DDtqKFSM27NBApdmj5KU0y4k5Y7K4QVTgovwIKkjjEhJC15IQ3hwrMbdH_i7r_Nzjvr67bRldo3Ydd_r6IO6n9Th436jAcFJM-5oNAT2Ilgm5hS48vfYyDqaFadzKqzWXU0y34A0mpv7A</recordid><startdate>20231005</startdate><enddate>20231005</enddate><creator>Ollila, Meri-Maija</creator><creator>Arffman, Riikka K</creator><creator>Morin-Papunen, Laure</creator><creator>Korhonen, Elisa</creator><creator>Gissler, Mika</creator><creator>Piltonen, Terhi T</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20231005</creationdate><title>OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk</title><author>Ollila, Meri-Maija ; Arffman, Riikka K ; Morin-Papunen, Laure ; Korhonen, Elisa ; Gissler, Mika ; Piltonen, Terhi T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1952-4b3ad2b27a34cb819afbb81fb984d7c4dc66c6d76e61c172d336672f497b046e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Reproductive Endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ollila, Meri-Maija</creatorcontrib><creatorcontrib>Arffman, Riikka K</creatorcontrib><creatorcontrib>Morin-Papunen, Laure</creatorcontrib><creatorcontrib>Korhonen, Elisa</creatorcontrib><creatorcontrib>Gissler, Mika</creatorcontrib><creatorcontrib>Piltonen, Terhi T</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the Endocrine Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ollila, Meri-Maija</au><au>Arffman, Riikka K</au><au>Morin-Papunen, Laure</au><au>Korhonen, Elisa</au><au>Gissler, Mika</au><au>Piltonen, Terhi T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk</atitle><jtitle>Journal of the Endocrine Society</jtitle><date>2023-10-05</date><risdate>2023</risdate><volume>7</volume><issue>Supplement_1</issue><issn>2472-1972</issn><eissn>2472-1972</eissn><abstract>Disclosure: M. Ollila: None. R.K. Arffman: None. L. Morin-Papunen: None. E. Korhonen: None. M. Gissler: None. T.T. Piltonen: None. Women with polycystic ovary syndrome (PCOS) are burdened with multimorbidity, but there is only limited knowledge on mortality. Here, we investigated in a register-based 1:3 matched case-control study, whether women with PCOS have increased all-cause, or cause-specific mortality compared to women without PCOS. Women with PCOS (i.e., cases) were identified from the Finnish Care Register for Health Care using the International Classification of Diseases, Revisions 8, 9, and 10 (ICD-8, ICD-9, and ICD-10, respectively) codes for PCOS (ICD-10: E28.2, ICD-9: 256.4, ICD-8: 256.9). Control women were matched according to the year of birth and residential area. The time and cause of death as well as the highest level of education were extracted from the register of Statistics Finland. The registers covered the years 1969-2019. Crude and education-adjusted Cox proportional hazard models were applied, and the results were reported as hazard ratio (HR) with 95% confidence intervals. The study included 9,839 women with PCOS and 70,705 controls. Overall, 1,003 controls and 177 women with PCOS died during the follow-up period. The women with PCOS died significantly younger than the controls (51.4 ± 16.4 versus 52.9 ± 16.6 years, p&lt;0.001). In the unadjusted analysis, women with PCOS had increased overall mortality (HR=1.53 [1.28-1.84]) as well as increased mortality due to tumors (HR=1.42 [1.06-1.90]), endocrine, nutrition, or metabolic diseases (HR=2.45 [1.02-5.96]), and diseases of the circulatory system (HR=1.77 [1.19-2.62]). In the adjusted analysis, women with PCOS had increased overall mortality (HR=1.47 [1.23-1.76]), as well as increased mortality due to diseases of the circulatory system (HR=1.67 [1.13-2.48]) and tumors (HR=1.38 [1.04-1.85]). Regarding more specific causes of death, women with PCOS had increased mortality due to diabetes (HR=3.07 [1.16-8.08]), other diseases of the circulatory system (HR=2.07 [1.00-4.25]), and bronchitis (HR=3.61 [1.01-12.88]) in the adjusted analyses. In conclusion, PCOS is a severe lifelong syndrome that increases mortality. More emphasis should be targeted on the prevention and treatment of diabetes, circulatory diseases, tumors, and respiratory diseases in women with PCOS to reduce the mortality risk. Presentation Date: Sunday, June 18, 2023</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1210/jendso/bvad114.1712</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2472-1972
ispartof Journal of the Endocrine Society, 2023-10, Vol.7 (Supplement_1)
issn 2472-1972
2472-1972
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10554621
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford Journals Open Access Collection; PubMed Central
subjects Reproductive Endocrinology
title OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A09%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=OR35-06%20Polycystic%20Ovary%20Syndrome%20Is%20Associated%20With%20an%20Increased%20Mortality%20Risk&rft.jtitle=Journal%20of%20the%20Endocrine%20Society&rft.au=Ollila,%20Meri-Maija&rft.date=2023-10-05&rft.volume=7&rft.issue=Supplement_1&rft.issn=2472-1972&rft.eissn=2472-1972&rft_id=info:doi/10.1210/jendso/bvad114.1712&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_10554621%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true